During the Trading Day
| 21.72 |  +0.22 / +1.02% |
Data as of 3:59pm ET | Day’s Change | |
| 21.72 |  0.00 / 0.00% |
| Volume: 2.1K |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $891.5M |
Company Description
Meridian Bioscience, Inc. is a fully integrated life science company. The company manufactures, markets and distributes diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. It operates through three segments: U.S. Diagnostics, European Diagnostics and Life Science. The U.S. Diagnostics segment consists of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the U.S. and countries outside of Europe, Africa and the Middle East. The European Diagnostics segment consists of the sale and distribution of diagnostic test kits in Europe, Africa and the Middle East. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia, and the sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bioresearch reagents domestically and abroad. The company was founded by William J. Motto in 1977 and is headquartered in Cincinnati, OH.
Employees
Shareholders
| Other institutional | 49.59% |
| Mutual fund holders | 48.03% |
| Individual stakeholders | 4.08% |
Top Executives
| William J. Motto | Executive Chairman |
| John A. Kraeutler | CEO, Director & Head-Media Relations |
| Lawrence J. Baldini | Executive VP-Operations & Information Systems |
| Melissa A. Lueke | CFO, Secretary & Executive Vice President |
| Vecheslav A. Elagin | Executive Vice President-Research & Development |
.
